Health Care

Explore Personalis Inc.’s genomic breakthroughs and latest stock trends: $15.85 share price, stable market presence, and innovative cancer therapy insights.

Geron unveils new telomerase‑inhibitor data for myeloid malignancies, showing prolonged transfusion independence and predictive early blood‑cell declines.

Discover how Avant Brands Inc. is reshaping Canada’s cannabis market with handcrafted products and bold growth plans—analyzing stock volatility, market strategy, and future prospects.

ADMA Biologics drives plasma‑derived therapeutic innovation, boosting production capacity, supply resilience, and investor value in a growing biotech sector.

S&P 500’s modest 0.1 % decline amid a flurry of bank earnings reports.

Aurora Cannabis revamps leadership to boost governance and operational efficiency, aiming for sustainable growth in the evolving medical cannabis market.

Discover how Prelude Therapeutics’ oral small‑molecule cancer drugs could transform treatment, plus the latest stock trends and investment outlook.

Explore how Regencell Bioscience harnesses traditional medicine to tackle neurocognitive disorders, its Nasdaq journey, and the future of holistic biotech innovation.

Discover how S.M.A.I.O S.A. transforms spinal deformity surgery with its i-PLAN, i-PERFORM, and i-CHECK tools, boosting precision and patient outcomes.

Cosmos Health reports record Q3 revenue, forecasting 90‑plus M$ in 2026 as its drug, nutraceutical and medical device lines expand globally.